SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network ($ZBCN) is trending due to recent high-profile partnerships, including integration with World Liberty Finance for USD1 payroll and card services, alongside imminent Super App developments. The community is buzzing with excitement over its ISO 20022 and MiCA compliance, positioning it as an undervalued asset with real-world utility, often comparing it to early-stage XRP and XLM. Investors are keenly discussing long-term holding and staking, anticipating significant future growth in the blockchain payment sector.

Venus Concept, Inc. is a global medical technology company, which engages in the business of developing, commercializing, and selling minimally invasive and non-invasive medical aesthetic and hair restoration technologies. It operates under the United States and International geographical segments. The company was founded on November 22, 2002 and is headquartered in Toronto, Canada.

Venus Concept Inc

Venus Concept (VERO) is trending following news that Madryn Asset Management acquired a 91% stake, sparking intense debate among investors. While many anticipate a significant short squeeze and further price appreciation due to the extremely low public float, others caution about potential delisting or dilution as the company explores strategic alternatives.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is trending intensely following key regulatory approvals for its ANKTIVA treatment in Saudi Arabia for both bladder and lung cancer, coupled with strong preliminary revenue growth and positive clinical updates. The community is actively discussing the potential for a substantial short squeeze, fueled by significant trading volume and optimism surrounding the company's advancing oncology pipeline and its disruptive potential in cancer therapy.

Decentraland

Decentraland (MANA) is actively trending due to widespread community speculation around a significant partnership or integration with Apple's ecosystem, particularly concerning VR and Apple Pay support. This has ignited strong bullish sentiment, with many anticipating a new wave of metaverse mass adoption and substantial growth, while a vocal segment remains skeptical about the project's long-term utility. The conversation reflects a sharp divide on whether the metaverse narrative is poised for a major resurgence.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is experiencing heightened attention following recent analyst downgrades and growing market skepticism regarding the impact of AI competition, particularly from new offerings like Apple's creative suite. Community sentiment is sharply divided, with some investors drawing negative comparisons to other "AI-disrupted" companies and anticipating further declines, while others are aggressively buying, citing deeply oversold conditions, strong fundamentals, and consistent share buybacks.

RCI Hospitality Holdings, Inc. engages in the provision of live adult entertainment and dining experiences. It operates through the following segments: Nightclubs and Bombshells. The Nightclubs segment includes operating adult entertainment nightclubs. The Bombshells segment operates a restaurant and bar. The company was founded by Robert L. Watters in 1983 and is headquartered in Houston, TX.

RCI Hospitality Holdings Inc

RCI Hospitality Holdings is actively trending following the resignation of its CEO and CFO amidst serious allegations of bribery and tax fraud from the NY Attorney General. This news has polarized the community, with many viewing the company as a deep value opportunity due to its strong free cash flow and asset-rich real estate, while others raise concerns about management's past capital allocation and the potential impact of these legal challenges. The company's "Back to Basics" strategy, focusing on club acquisitions and share repurchases, remains a key talking point for investors navigating this uncertainty.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is a key discussion point among investors as anticipation builds for the upcoming Cohort 4 Atopic Dermatitis data for its novel ITK inhibitor, soquelitinib. The community is actively debating the potential for a transformative efficacy readout that could validate the platform across a wide range of autoimmune diseases. This pivotal data release, coupled with ongoing speculation about a potential partnership, is driving significant investor interest.

BlackRock Institutional Trust Company N.A. - iShares 7-10 Year Treasury Bond ETF

iShares 7-10 Year Treasury Bond ETF

IEF is trending as surging Treasury yields, driven by recent inflation and jobs data, are causing significant concern in the fixed-income market. The community is widely bearish on this asset class, actively discussing the breakout in 10-year yields and frequently advising to "avoid" longer-dated treasuries. This reflects broader anxieties about the Federal Reserve's rate path and the potential for prolonged higher rates.

XDC Network is an enterprise-ready hybrid Blockchain technology company optimized for international trade and finance. The XDC Network is powered by the native coin called XDC. The XDC protocol is architected to support smart contracts, 2000TPS, 2seconds transaction time, KYC to Masternodes (Validator Nodes). The XDC Chain (XinFin Digital Contract) uses XinFin Delegated Proof of Stake (XDPoS), with the intending to create a ‘highly-scalable, secure, permission, and commercial grade’ blockchain network. XinFin mainnet token XDC and also creates an opportunity to utilize the XinFin’s real-world use-cases such as TradeFinex.org, helps small and medium businesses or institutions originate their own financial requirements in a digital, fully structured manner so that they can distribute it to the bank or non-bank funders themselves using a common distribution standard.

XinFin Network

XDC is experiencing significant community buzz following its recent Binance US listing and anticipated Kraken integration, which are seen as key steps toward broader accessibility and institutional adoption. Despite some investor frustration over historically subdued price movements, many believe these developments, alongside ongoing partnerships in trade finance and Real-World Asset (RWA) tokenization, underscore its long-term utility and potential within the evolving digital economy.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer Inc. is experiencing a strong rally, largely driven by community buying interest that views a recent institutional downgrade as a manipulative play to acquire undervalued shares. This bullish sentiment is further fueled by strong demand for AI infrastructure, echoed by robust earnings from industry bellwethers, positioning SMCI as a key beneficiary in the burgeoning AI sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Buying: Sintx Technologies (NASDAQ:SINT) CIO Buys 8,200 Shares of Stock

Sintx Technologies, Inc. (NASDAQ:SINT - Get Free Report) CIO Gregg Honigblum acquired 8,200 shares of Sintx Technologies stock in a transaction that occurred on Monday, December 8th. The shares were...

Sintx Technologies (NASDAQ:SINT) CIO Gregg Honigblum Acquires 65,000 Shares

Sintx Technologies, Inc. (NASDAQ:SINT - Get Free Report) CIO Gregg Honigblum purchased 65,000 shares of Sintx Technologies stock in a transaction dated Friday, December 5th. The shares were bought at...

Envoy Medical, Inc. (COCH) Reports Q3 Loss, Misses Revenue Estimates

Envoy Medical, Inc. (COCH) delivered earnings and revenue surprises of -29.63% and -23.64%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Tops Revenue Estimates

Tandem Diabetes Care (TNDM) delivered earnings and revenue surprises of 0.00% and +4.83%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Neuronetics (STIM) Reports Q3 Loss, Misses Revenue Estimates

Neuronetics (STIM) delivered earnings and revenue surprises of -18.18% and -2.21%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Integer (ITGR) Beats Q3 Earnings and Revenue Estimates

Integer (ITGR) delivered earnings and revenue surprises of +6.55% and +0.41%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

What Makes SINTX TECHNOLOGIES, INC. (SINT) a Strong Momentum Stock: Buy Now?

Does SINTX TECHNOLOGIES, INC. (SINT) have what it takes to be a top stock pick for momentum investors? Let's find out.

Sensus Healthcare, Inc. (SRTS) Reports Q2 Loss, Misses Revenue Estimates

Sensus Healthcare (SRTS) delivered earnings and revenue surprises of -700.00% and -16.88%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Intuitive Surgical, Inc. (ISRG) Q2 Earnings and Revenues Top Estimates

Intuitive Surgical (ISRG) delivered earnings and revenue surprises of +14.06% and +3.93%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Retail chatter around Sintx Technologies surged on Thursday following the company's announcement of a newly issued international patent and the formation of a wholly-owned agribiotech subsidiary.Sintx Technologies closed 8.3% lower at $2.81 on Thursday, with shares slipping another 3.2% to $2.72 in after-hours trading.The advanced ceramics developer for medical applications said it has received an international Patent, which protects the antimicrobial applications of its silicon nitride compound within agricultural environments.&nbsp;The patent forms part of a broader intellectual property portfolio addressing the antimicrobial crop protection market.SINTX also announced the establishment of Sintx Agribiotech Inc., an independently operated unit tasked with developing and commercializing silicon nitride-based technologies for agricultural and environmental applications.&nbsp;The subsidiary will operate separately from the firm’s core medical device business and have its own management team.CEO Eric Olson said the company sees wine production as one of the most promising early applications for the new technology.Internal research previously published by the company showed that silicon nitride reduced the growth and sporulation of Plasmopara viticola, the pathogen responsible for grapevine downy mildew, by up to 90% on grape varieties such as Cabernet Sauvignon and Cannonau.&nbsp;The study indicated that silicon nitride caused no phytotoxic effects and may offer a sustainable alternative to copper-based fungicides, which face increasing regulatory scrutiny.On Stocktwits, retail sentiment was ‘extremely bullish’ amid a 7,500% surge in 24-hour message volume.One user viewed the recent pullback in Sintx shares as overextended and suggested accumulating the stock below key price levels.<stembedurl>https://stocktwits.com/amda/message/615507468</stembedurl>Meanwhile, another user drew parallels to a previous patent-related move in February that preceded a brief rally.<stembedurl>https://stocktwits.com/MathiasMatheson/message/615511807</stembedurl>The stock has declined 23% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Sintx Technologies Draws Heavy Retail Buzz On New Patent Push, Subsidiary

The company announced the issuance of an international patent for its silicon nitride’s antimicrobial agricultural uses and launched a separate agribiotech subsidiary to commercialize these technologies.

Equity

SINTX Technologies, Inc. is a ceramics company, which engages in the development and commercialization of silicon nitride for medical and non-medical applications. It markets spinal fusion products and develops products for use in total hip and knee joint replacements. The company was founded by Aaron A. Hofmann and Ashok C. Khandkar in December 1996 and is headquartered in Salt Lake City, UT.

SINT
SINTX Technologies Inc

Feed

News

Sentiment

Fundamentals

Info

Latest SINT News

SINTSINTX Technologies Inc